Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 445

Artemis Health arcs to $25m series C

Hearst Health Ventures contributed to a BVP-led round that boosted the health benefits data platform's total funding to about $51m.

Mar 18, 2019

Corporate venturing deal net: 11-15 March 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Mar 15, 2019

Gencove adds $3m to funding sequence

New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.

Mar 15, 2019

Yunhu delivers series A-plus

The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.

Mar 15, 2019

TriNetX triumphs in $40m series D

The healthcare research platform has increased its total funding to $102m following a Merck GHI-led round that included Itochu Technology Ventures and Mitsui.

Mar 15, 2019

Aldrich administers $41m to eHealth

The medical record retrieval software provider, which received funding from Merck & Co in 2013, has secured $41m from Aldrich Capital Partners.

Mar 15, 2019

Well Doc recuperates with $1.6m

Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.

Mar 14, 2019

Docquity rocks $11m series B round

The physician-based social media platform has raised $11m in a round co-led by Itochu, which supplied $6m, and existing backer Singapore Press Holdings.

Mar 14, 2019

Verano to reap $850m in Harvest acquisition

Scythian Biosciences-backed cannabis facilities operator Verano has agreed to an $850m acquisition by Harvest Health and Recreation in an all-stock transaction.

Mar 13, 2019

InventisBio invites Eli Lilly to $70m series C

Lilly Asia Ventures has returned for a series C round that boosted the total raised by the cancer and metabolic disease drug developer to $100m.

Mar 13, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here